Skip to main content
Premium Trial:

Request an Annual Quote

MolecularMD Gets CE Mark for CDx Assay Used in Daiichi Sankyo Clinical Trial

NEW YORK (GenomeWeb) – Molecular diagnostics company MolecularMD announced today that it has received CE marking for a custom companion diagnostic it developed for a Daiichi Sankyo clinical trial.

The Phase II trial is testing a cancer therapy in Europe, MolecularMD said. The firm's assay is being used to select patients to participate.

"Identifying the precise subset of patients who may respond to our compound helps to fully assess its potential efficacy and safety profile," Antoine Yver, executive VP and global head of Daiichi Sankyo's oncology R&D, said in a statement.

The deal with Daiichi Sankyo is one of several similar agreements MolecularMD has signed with prominent biopharmaceutical companies, the firm added. "MolecularMD is entirely focused on accelerating development of precision oncology medicines. Our work with Daiichi Sankyo demonstrates our ability to support a wide spectrum of clinical and regulatory strategies," said CEO Dan Snyder in a statement.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.